Action of antitumoral platinum complexes on in vitro platelet functions
- 1 April 1998
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 110 (3) , 203-220
- https://doi.org/10.1016/s0009-2797(98)00014-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Heavy metal revivalNature, 1995
- Type IIB von Willebrand Factor Induces Phospholipase A2 Activation and Cytosolic Ca2+ Increase in PlateletsBiochemical and Biophysical Research Communications, 1995
- Phase I study of high-dose cisplatin, ifosfamide, and etoposideCancer Chemotherapy and Pharmacology, 1994
- Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in ratsBritish Journal of Cancer, 1993
- New Cisplatin Analogues in DevelopmentDrugs, 1993
- Cisplatin‐induced platelet activation requires mononuclear cells: role of GMP‐140 and modulation of procoagulant activityBritish Journal of Haematology, 1993
- Platelets acquire a secretion defect after high-dose chemotherapyCancer, 1990
- Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responsesBiochemical and Biophysical Research Communications, 1988
- CisplatinAnnals of Internal Medicine, 1984
- The renal toxicity of cancer chemotherapeutic agentsCancer Treatment Reviews, 1982